Abstract
Tumor necrosis factor inhibitors and methotrexate are associated with decreased COVID-19-related hospitalization: Follow up of “Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors and methotrexate”
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have